Not Fooled by Financial Botox: Top 10 Short Seller Targets

By
A A A
Share |

(List compiled by Becca Lipman. Data sourced from Finviz. Disclaimer: Becca own shares of FSLR)

"Just like Botox is a temporary solution to aging skin, Band-Aid solutions from the central banks have caused toxic side effects across the world, and with that, Financial Botox was born." - Interview with Satyajit Das on Australia's The Morning Show

Satyajit Das, author and finance expert who predicted much of the Global Financial Crisis back in 2006, has coined a new financial term: "Financial Botox."

The term draws a surprisingly eloquent parallel between the temporary skin improvement drug called Botox, and the government pumping out money in an attempt to cure the financial crisis.

Das allows that the spending was wise at the onset.

"What they did initially made a lot of sense, they flooded money in because they didn't want what was happening in 2007-2008 turning into a great depression."

Yet the underlying problems of debt, public and private, was not fully addressed. In fact, governments continued to borrow in order to inject more money (Botox) into the systems and prop up demand. Eventually, as the Band-Aids fall off, economies are left with the market volatility such as what we've been seeing in the markets over the past 4 weeks.

Das also emphasizes the interconnectivity of nations in the global debt crisis. He writes in the Financial Times, "The ability of sovereigns to finance themselves is in question and there is no one to backstop the governments themselves. Contagion from a sovereign debt crisis is especially pernicious, and different to that of 2008."

The European Nation is already facing this problem on a large scale.

He goes on to say, "Government bonds are traditionally havens as well as the preferred form of collateral used to secure borrowing and other obligations. If the quality of stronger government issuers were contaminated, this would have far-reaching consequences for financial activity."

Central banks, pension funds, and insurers all have significant investments in government bonds - as their integrity wavers so does the functionality of these systems. It seems the Botox is wearing off.

Das's tips to stay out of trouble:

1. Avoid debt - for starters, reduce your mortgages
2. Save more - Healthcare and retirement will cost more, and governments may not be able to do it
3. Invest in things that produce income - such as dividend stocks, or educate yourself to earn more money
4. Return of your money is more important than return on your money - the return you are looking for is income, such as steady dividends 
5. Trust only yourself

To help you analyze the market's reaction to the "Financial Botox" we took a look at short seller activity. 

Below is a list of the top 10 S&P 500 financial stocks with the highest short floats. Short sellers think the short term solutions won't solve the long-term problems at these companies--do you agree?

Analyze These Ideas (Tools Will Open In A New Window)

1. Access a thorough description of all companies mentioned
2. Compare analyst ratings for all stocks mentioned below
3. Visualize annual returns for all stocks mentioned

1. First Solar, Inc. (FSLR): Semiconductor Industry. Market cap of $8.14B. Current price at $93.07. Short float at 32.95%. The stock is currently stuck in a downtrend, trading -11.2% below its SMA20, -20.22% below its SMA50, and -30.51% below its SMA200. It's been a rough couple of days for the stock, losing 9.7% over the last week.

2. MetLife, Inc. (MET): Life Insurance Industry. Market cap of $33.45B. Current price at $32.06. Short float at 26.89%. The stock is currently stuck in a downtrend, trading -9.33% below its SMA20, -18.24% below its SMA50, and -25.41% below its SMA200. It's been a rough couple of days for the stock, losing 5.92% over the last week.

3. GameStop Corp. (GME): Electronics Stores Industry. Market cap of $3.19B. Current price at $22.78. Short float at 24.93%. The stock has had a couple of great days, gaining 5.56% over the last week.

4. SUPERVALU Inc. (SVU): Grocery Stores Industry. Market cap of $1.47B. Current price at $6.85. Short float at 20.35%. The stock is currently stuck in a downtrend, trading -9.33% below its SMA20, -18.78% below its SMA50, and -22.1% below its SMA200. The stock has performed poorly over the last month, losing 18.66%.

5. Netflix, Inc. (NFLX): Music & Video Stores Industry. Market cap of $11.53B. Current price at $212.57. Short float at 18.13%. The stock is currently stuck in a downtrend, trading -11.77% below its SMA20, -18.14% below its SMA50, and -5.88% below its SMA200. It's been a rough couple of days for the stock, losing 8.16% over the last week.

6. Lennar Corp. (LEN): Residential Construction Industry. Market cap of $2.38B. Current price at $12.77. Short float at 17.32%. The stock is currently stuck in a downtrend, trading -15.21% below its SMA20, -24.36% below its SMA50, and -29.33% below its SMA200. It's been a rough couple of days for the stock, losing 13.6% over the last week.

7. J. C. Penney Company, Inc. (JCP): Department Stores Industry. Market cap of $5.55B. Current price at $26.8. Short float at 17.01%. The stock has performed poorly over the last month, losing 16.69%.

8. Vulcan Materials Company (VMC): General Building Materials Industry. Market cap of $4.12B. Current price at $32.85. Short float at 16.03%. Offers a good dividend, and appears to have good liquidity to back it up--dividend yield at 3.13%, current ratio at 2.12, and quick ratio at 1.34. The stock has performed poorly over the last month, losing 10.72%.

9. Federated Investors, Inc. (FII): Asset Management Industry. Market cap of $1.75B. Current price at $16.91. Short float at 15.88%. The stock is currently stuck in a downtrend, trading -9.14% below its SMA20, -20.92% below its SMA50, and -30.8% below its SMA200. The stock has performed poorly over the last month, losing 22.91%.

10. Novellus Systems, Inc. (NVLS): Semiconductor Equipment & Materials Industry. Market cap of $1.92B. Current price at $27.21. Short float at 15.79%. Might be undervalued at current levels, with a PEG ratio at 0.68, and P/FCF ratio at 5.9. The stock is currently stuck in a downtrend, trading -6.07% below its SMA20, -14.77% below its SMA50, and -20.29% below its SMA200. The stock has performed poorly over the last month, losing 15.9%.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Investing Ideas , Stocks


Kapitall

Kapitall

More from Kapitall:

Related Videos

Stocks

Referenced

Most Active by Volume

89,970,926
  • $16.15 ▲ 0.12%
77,131,582
  • $58.94 ▼ 1.31%
67,336,935
  • $26.56 ▲ 1.68%
48,814,124
  • $86.20 ▲ 0.02%
47,526,126
  • $23.21 ▲ 0.78%
44,660,424
  • $23.91 ▲ 6.36%
38,799,699
  • $4.289 ▲ 4.36%
36,199,890
  • $40.01 ▼ 0.97%
As of 4/17/2014, 04:07 PM